NeoStem Awarded Grant To Develop New Treatment for Skin Wounds In Scleroderma PDF Print E-mail
Wednesday, 18 September 2013 13:40
NeoStem, as a leader in the emerging cellular therapy industry, announced that it had received an award under the Small Business Innovative Research Program of $147,765 for the “Development of Adult Pluripotent Very Small Embryonic Like (VSEL) Stem Cells to Treat Skin Wounds in Scleroderma” from the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH-NIAMS). This award will fund studies to investigate the potential of very small embryonic-like stem cells (VSELs™) in treating difficult to heal wounds in an animal model of Scleroderma.

VSEL™ Technology offers the potential to go beyond the paracrine effect, yielding cells that actually differentiate into the target tissue and create true cellular regeneration.

The grant will support research to be headed by Denis O. Rodgerson, Ph.D., Director of Grants and Academic Liaison of NeoStem, and Dr. Vincent Falanga, M.D., The Barbara A. Gilchrest Professor of Dermatology and Professor of Biochemistry at the Boston University School of Medicine.

The study will employ the tight skin (Tsk) mouse to test the potential wound healing capabilities of autologous VSELs™ in treating difficult to heal skin ulcers in this disease. The Tsk mouse carries a heterogeneous mutation for the fibrillin-1 gene and rapidly exhibits the characteristic tight and thickened skin phenotype of Scleroderma patients. Depending on the results of the study, the Company may quality for up to an additional $1.5 million phase 2 grant for the indication from NIH-NIAMS.

“Our collaboration with Dr. Falanga, a recognized expert in the management of chronic wounds and fibrosis, offers NeoStem a solid foundation to advance its investigation into the use of  human VSELs™ in treating skin wounds and a host of other degenerative diseases and disorders in humans, including scleroderma,” said Dr. Denis O. Rodgerson.  “This study has the potential to advance  treatments that could one day help patients suffering from this and other debilitating autoimmune diseases.”

Source: NeoStem Press Release

 
More articles :

» Caribbean Autoimmune Disease Summit 2011

The Caribbean Autoimmune Disease Summit 2011, is scheduled to be held this Sunday 2nd October, 2011 at the , Port of Spain, Trinidad. Hosted by the Caribbean Investor Network, the Summit aims to raise awareness of Autoimmune Diseases, their...

» Studies Show That Natural Probiotic Supplements Can Help Reduce and Treat Autoimmune Disease Symptoms

Most consumers are familiar with the dangers of disease-causing bacteria; but over the last several decades, medical professionals and lay consumers alike have discovered a host of proven and potential benefits to be had from the consumption of...

» Scleroderma Study Identifies Roadblocks To Employment

In the United States, the work disability rate for people with , also known as systemic sclerosis, is two to three times that of people with some other rheumatic conditions, according to research data from investigators at The (UTHealth) Medical...

» We Need Your Help!

Today, the Scleroderma Care Foundation embarks upon a mission of vital importance, and we are counting on your help. One of our dearest patients and friend, , is on the verge of Renal or and we are seeking out a qualified kidney donor. Currently,...

» Scientists and Clinicians Address Diagnosis and Treatment for Autoimmune and Autoinflammatory Diseases

Autoimmune and autoinflammatory diseases are a major health issue. The National Institutes of Health reports that up to 23.5 million Americans are afflicted. The American Autoimmune Related Diseases Association reports the number is closer to 50...

» Mouth Exercises For Scleroderma

The loss of facial mobility may restrict the ability to chew foods and perform adequate moth hygiene. Below is some advice on maintaining facial mobility through exercise.INSTRUCTIONS:Do exercises in front of a mirror. Massage (firm touch) the...